Screen broadcasting solution for SANOFI-AVENTIS

...

CAST NEW

Our CAST solution could allow SANOFI-AVENTIS to broadcast personalized messages on its screen park, via our CAST platform.

Your screens

Dublin
Entrance
Painting workshop
Cork
Second floor
Cutting workshop
Limerick
Meeting room
Assembly workshop

1 Plug the CASTBox's to your screens

HDMI / USB / WIFI / No A/C

2 Create a Message

From an image, a video, or using a custom template ... (the possibilities are endless)

Choose the screens you want to display on

You can also define the period concerned (start and end).

4 Spread and monitor

Publish your content in a few seconds, monitor your screens.

YOUR ADMIN

CAST

MESSAGE EDITOR

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 1

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 1

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 1

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 2

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 2

BROADCAST TO SCREEN

1
2
3

MESSAGE EDITOR

MESSAGE 2

BROADCAST TO SCREEN

1
2
3

Launch the demo

Pricing

3€ Ex. VAT per day by connected screen

Security

Our technology is based on the latest secure protocols SSL, HTTPS, CAPTCHAv3, ENCRYPT, SNAPSHOTS in order to guarantee you a robust service. Our technology is hosted in France at GANDI.

Reliability

A cache system allows the service to be maintained in the event of an Internet outage. Our servers are backed up regularly.

Reactivity

Our support service is available 6 days a week from 9 a.m. to 7 p.m., by phone, e-mail or instant messaging.

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013[update] the world's fifth-largest by prescription sales.[3] Originally, the company was formed in 1973 and the current incarnation was formed as Sanofi-Aventis in 2004, by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers. It changed its name to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.[4]Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).[5] In 2017, Sanofi's dengue vaccine Dengvaxia garnered controversy because it caused some vaccinated young children to have more cases of severe dengue. The New York Times cited criticism for Sanofi's aggressive ad campaign despite the fact that this new vaccine was not completely safe.[6]

Source credits : Wikipedia / Unsplash

Welcome